Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection

Medical Microbiology and Immunology

Volumn 200, Issue 2, 2011, Pages 109-113

  Kampmann, Susanne E ^a,c   Schindele, Birgit ^b   Apelt, Luise ^b   Bührer, Christoph ^a   Garten, Lars ^a   Weizsaecker, Katharina ^a   Krüger, Detlev H ^a   Ehlers, Bernhard ^b   Hofmann, Jörg ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

HCMV infection; Pyrosequencing; Resistance associated mutations

Indexed keywords

DIURETIC AGENT; FOSCARNET; GANCICLOVIR; OXYGEN; SILDENAFIL; SINGLE STRANDED DNA; VALGANCICLOVIR;

ARTICLE; AUTOPSY; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DEATH; DNA SEQUENCE; FEMALE; GENETIC RESISTANCE; GENETIC VARIABILITY; GESTATION PERIOD; HUMAN; MUTATIONAL ANALYSIS; NEUTROPHIL COUNT; NEWBORN; NONHUMAN; POPULATION DIFFERENTIATION; PREMATURITY; PRIORITY JOURNAL; PYROSEQUENCING; SIDE EFFECT; UL97 GENE; VIRUS GENE; VIRUS MUTANT;

ANTIVIRAL AGENTS; AUTOPSY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GANCICLOVIR; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 79955677893     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-010-0181-y     Document Type: Article

References (18)

1. Schleiss MR, McVoy MA (2004) Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev Anti Infect Ther 2:389-403 (Pubitemid 38745098)
2. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF (1999) Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104:55-60 (Pubitemid 29315847)
3. Kimberlin DW, Lin CY, Sanchez PJ et al (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143:16-25 (Pubitemid 36928564)
4. Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, Boucher C (1999) Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol 37:2291-2296 (Pubitemid 29277794)
5. Ronaghi M (2001) Pyrosequencing sheds light on DNA sequencing. Genome Res 11:3-11
6. Fox S, Filichkin S, Mockler TC (2009) Applications of ultra-high-throughput sequencing. Methods Mol Biol 553:79-108
7. Mori T, Okamoto S, Matsuoka S et al (2000) Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 25:765-769 (Pubitemid 30189518)
8. Prix L, Hamprecht K, Holzhuter B, Handgretinger R, Klingebiel T, Jahn G (1999) Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J Infect Dis 180:491-495 (Pubitemid 30256333)
9. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467
10. Schindele B, Apelt L, Hofmann J et al (2010) Improved detection of mutated HCMV UL97 by pyrosequencing. Antimicrob Agents Chemother (in press)
11. Galli L, Novelli A, Chiappini E et al (2007) Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants. Pediatr Infect Dis J 26:451-453 (Pubitemid 46789332)
12. Gilbert C, Boivin G (2005) Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother 49:873-883 (Pubitemid 40327699)
13. Bousfiha A, Picard C, Boisson-Dupuis S et al (2010) Primary immunodeficiencies of protective immunity to primary infections. Clin Immunol 135:204-209
14. Casrouge A, Zhang SY, Eidenschenk C et al (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308-312 (Pubitemid 44571977)
15. Zhang SY, Jouanguy E, Ugolini S et al (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527 (Pubitemid 47417427)
16. Bassiri H, Janice Yeo WC, Rothman J et al (2008) X-linked lymphoproliferative disease (XLP): a model of impaired antiviral, anti-tumor and humoral immune responses. Immunol Res 42:145-159
17. Castor J, Cook L, Corey L et al (2007) Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. J Clin Microbiol 45:2681-2683 (Pubitemid 47295503)
18. Chou S (2008) Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 18:233-246